Insulin signaling and pharmacology in humans and in corals

Once thought to be a unique capability of the Langerhans islets in the pancreas of mammals, insulin (INS) signaling is now recognized as an evolutionarily ancient function going back to prokaryotes. INS is ubiquitously present not only in humans but also in unicellular eukaryotes, fungi, worms, and...

Full description

Bibliographic Details
Main Authors: Meghana Hosahalli Shivananda Murthy, Paniz Jasbi, Whitney Lowe, Lokender Kumar, Monsurat Olaosebikan, Liza Roger, Jinkyu Yang, Nastassja Lewinski, Noah Daniels, Lenore Cowen, Judith Klein-Seetharaman
Format: Article
Language:English
Published: PeerJ Inc. 2024-01-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/16804.pdf
Description
Summary:Once thought to be a unique capability of the Langerhans islets in the pancreas of mammals, insulin (INS) signaling is now recognized as an evolutionarily ancient function going back to prokaryotes. INS is ubiquitously present not only in humans but also in unicellular eukaryotes, fungi, worms, and Drosophila. Remote homologue identification also supports the presence of INS and INS receptor in corals where the availability of glucose is largely dependent on the photosynthetic activity of the symbiotic algae. The cnidarian animal host of corals operates together with a 20,000-sized microbiome, in direct analogy to the human gut microbiome. In humans, aberrant INS signaling is the hallmark of metabolic disease, and is thought to play a major role in aging, and age-related diseases, such as Alzheimer’s disease. We here would like to argue that a broader view of INS beyond its human homeostasis function may help us understand other organisms, and in turn, studying those non-model organisms may enable a novel view of the human INS signaling system. To this end, we here review INS signaling from a new angle, by drawing analogies between humans and corals at the molecular level.
ISSN:2167-8359